John Hood

This inventor holds 123 USPTO granted patents and 15 published patent applications, plus 5 CIPO patents and 18 EPO patents, primarily in Wnt Signaling Pathway (CPC class C07D471-04). Top assignees: Samumed, LLC, Biosplice Therapeutics, Inc., Targegen, Inc.. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Hood. Retrieved from https://idiyas.com/inventor/john-hood

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 123 (Patent Applications = 15)

% Patents Active = 95.1

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 18 (Patent Applications = 28)

Average Co-Inventor Count = 3.8

ph-index = 34

Forward Citations = 2,915(Granted Patents)

Forward Citations (Not Self Cited) = 757(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Solana Beach, CA (US) (2006)
San Deigo, CA (US) (2017)
San Diego, CA (US) (2006 - 2023)
Del Mar, CA (US) (2022 - 2023)

Company Filing History:

Biosplice Therapeutics, Inc.

Endeavor Biomedicines, Inc.

patents

5. 3 out of 1,208

Scripps Research Institute

patents

6. 2 out of 5,512

Leland Stanford Junior University

patents

7. 1 out of 4

Impact Biomedicines, Inc.

patents

where one patent can have more than one assignee

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

Lung Function

Fibrosis Treatments

Wnt Signaling

Indazole Inhibitors

Gamma-Diketones

Anti-Inflammatory

Osteoarthritis

Aging Skin

Therapeutic Uses

Carboxamides

Myeloproliferative Disorders

Pyrazolo Compounds

123 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12605380 - Methods of improving lung function (2026-04-21),

2. 12605379 - Methods of improving lung function (2026-04-21),

3. 12447148 - Methods of improving lung function (2025-10-21),

4. 12295954 - Methods of treating fibrosis (2025-05-13),

5. 12213974 - Methods of treating fibrosis (2025-02-04),

6. 11839679 - Gamma-diketones for treatment and prevention of aging skin and wrinkles (2023-12-12),

7. 11780823 - Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors (2023-10-10),

8. 11697649 - Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof (2023-07-11),

9. 11684615 - Methods of using indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors (2023-06-27),

10. 11673885 - γ-diketones as Wnt/β-catenin signaling pathway activators (2023-06-13),

11. 11667632 - 2-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereof (2023-06-06),

12. 11628167 - Method of treating fibrosis (2023-04-18),

13. 11560378 - Treatment of osteoarthritis (2023-01-24),

14. 11400092 - Methods of treating myeloproliferative disorders (2022-08-02),

15. 11077046 - Gamma-diketones for treatment and prevention of aging skin and wrinkles (2021-08-03),

Title: The Innovative Work of Inventor John Hood

Introduction:

John Hood, a prolific inventor based in San Diego, CA, has made significant contributions to the field of skincare and medical treatment through his numerous patents. With a total of 118 patents to his name, Hood is a trailblazer in the world of innovation.

Latest Patents:

Hood's latest patents showcase his dedication to improving aesthetics and addressing various medical conditions. He recently patented "Gamma-diketones for treatment and prevention of aging skin and wrinkles," focusing on compounds that enhance skin appearance. Additionally, his invention of "Indazole-3-carboxamides as Wnt/β-catenin signaling pathway inhibitors" demonstrates his commitment to advancing treatment options for diseases related to cellular signaling pathways.

Career Highlights:

Throughout his career, Hood has worked with prominent companies such as Samumed, LLC and Biosplice Therapeutics, Inc. His expertise and innovative mindset have driven groundbreaking research and development in the skincare and medical sectors.

Collaborations:

Collaborating with individuals like Sunil Kumar KC and David Mark Wallace has enriched Hood's inventive journey. Together, they have explored new possibilities, shared insights, and pushed boundaries in the pursuit of cutting-edge solutions to complex challenges.

Conclusion:

Inventor John Hood's remarkable achievements in the realm of patents exemplify his passion for innovation and his unwavering commitment to making a positive impact on skincare and medical treatments. His inventive spirit continues to inspire and shape the future of these industries, leaving a lasting legacy of ingenuity and progress.

Profile summary based on public USPTO records.